Jointown Pharmaceutical Group (600998.SH) has obtained approval from the China Securities Regulatory Commission for the public offering of a REITs based on pharmaceutical warehouse logistics infrastructure.

Jointown Pharmaceutical Group (600998.SH) Announcement: On December 24, 2024, the China Securities Regulatory Commission issued the "Approval for the Registration of Huatai Jointown Pharmaceutical Group Medical Warehousing and Logistics Closed-End Infrastructure Securities Investment Fund" [CSRC Permit No. 1902 of 2024]. The main content of the approval is as follows: 1. Approval to register the Huatai Jointown Pharmaceutical Group Medical Warehousing and Logistics Closed-End Infrastructure Securities Investment Fund, with a fund type of contract-type closed-end and a fund contract term of 39 years. 2. Approval for a total fund raising amount of 400 million shares. 3. Approval for Huatai Fund Management Co., Ltd. to be the fund manager and Industrial Bank Co., Ltd. to be the fund custodian. 4. The fund must conduct fund raising activities within 6 months from the date of this approval, and the fund raising period shall not exceed 3 months from the date of share issuance.